Log in to save to my catalogue

1237. Inpatients with a beta-lactam antibiotic allergy label (BAAL) and unrevealed tolerance: A prev...

1237. Inpatients with a beta-lactam antibiotic allergy label (BAAL) and unrevealed tolerance: A prev...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1093_ofid_ofad500_1077

1237. Inpatients with a beta-lactam antibiotic allergy label (BAAL) and unrevealed tolerance: A prevalence study aimed to prioritize non-invasive delabeling for antimicrobial stewardship programs

About this item

Full title

1237. Inpatients with a beta-lactam antibiotic allergy label (BAAL) and unrevealed tolerance: A prevalence study aimed to prioritize non-invasive delabeling for antimicrobial stewardship programs

Publisher

US: Oxford University Press

Journal title

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Background
This study aimed to use data analytics to retrospectively identify the prevalence of inpatients across a system of hospitals with a BAAL who received and tolerated the culprit or related beta-lactam (BL) without proper documentation in the allergy profile of the electronic medical record (EMR). Findings from this study cou...

Alternative Titles

Full title

1237. Inpatients with a beta-lactam antibiotic allergy label (BAAL) and unrevealed tolerance: A prevalence study aimed to prioritize non-invasive delabeling for antimicrobial stewardship programs

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1093_ofid_ofad500_1077

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1093_ofid_ofad500_1077

Other Identifiers

ISSN

2328-8957

E-ISSN

2328-8957

DOI

10.1093/ofid/ofad500.1077

How to access this item